Unlocking the Potential of Biosimilars: Strategies and Tools for Success
November 5, 2025 | 2:30 pm CST
As biologic treatments continue to drive healthcare costs—sometimes exceeding $4 million per dose—biosimilars offer a promising solution and potential cost savings. Join us to discover effective strategies and practical tools to better understand how biosimilars can reduce medical and pharmacy expenses while maintaining high-quality patient care.
Panelists:
Alex Keeton, Executive Director of the Biosimilars Council and SVP of Policy, Association for Accessible Medicines
Alex Keeton is the Executive Director of the Biosimilars Council and leads the policy team at the Association for Accessible Medicines (AAM). A healthcare policy and government affairs leader with extensive experience on issues related to health insurance and prescription drugs, he most recently served as Vice President, Pharmacy Care Services, at UnitedHealth Group, where he shaped enterprise strategy around drug affordability and pharmacy benefits.
Denise Giambalvo, Executive Director, Washington Health Alliance
Denise Giambalvo is the Washington Health Alliance’s fifth executive director, leading the organization efforts to improve quality, affordability and accessibility of care in Washington state. She was elevated to the role of executive director after more than three years with the WHA. She first joined WHA as its Director of Purchaser Strategies, and she most recently was WHA’s Director of Member Engagement and Business Strategy. In these roles, she spearheaded successful purchaser-focused initiatives along with expanding WHA’s offerings to include well-attended forums, workgroups and webinars.
Webinar Sponsored by:
